Alderson, P. (2001). Down’s syndrome: Cost, quality and value of life. Social Science and Medicine, 53(5), 627–638. https://doi.org/10.1016/S0277-9536(00)00365-8
Antonarakis, S. E., Skotko, B. G., Rafii, M. S., Strydom, A., Pape, S. E., Bianchi, D. W., Sherman, S. L., & Reeves, R. H. (2020). Downsyndrome. Nature Reviews Disease Primers, 6, 1–20. https://doi.org/10.1038/s41572-019-0143-7
Asch, A. (2003). Disability equality and prenatal testing: Contradictory or compatible. Florida State University Law Review, 30(2), 315–342.
Bailey, D. B., Lewis, M. A., Roche, M., & Powell, C. M. (2014). Family relations in the genomic era: Communicating about intergenerational transmission of risk for disability. Family Relations, 63(1), 85–100. https://doi.org/10.1111/fare.12054
Barter, B., Hastings, R. P., Williams, R., & Huws, J. C. (2017). Perceptions and discourses relating to genetic testing: Interviews with people with Down syndrome. Journal of Applied Research in Intellectual Disabilities, 30(2), 395–406. https://doi.org/10.1111/jar.12256
Benston, S. (2016). CRISPR, a crossroads in genetic intervention: Pitting the right to health against the right to disability. Laws, 5(1), 5. https://doi.org/10.3390/laws5010005
Article PubMed PubMed Central Google Scholar
Bilkey, G. A., Burns, B. L., Coles, E. P., Bowman, F. L., Beilby, J. P., Pachter, N. S., Baynam, G., Dawkins, H. J. S., Nowak, K. J., & Weeramanthri, T. S. (2019). Genomic testing for human health and disease across the life cycle: Applications and ethical, legal, and social challenges. Frontiers in Public Health, 7, 40. https://doi.org/10.3389/fpubh.2019.00040
Article PubMed PubMed Central Google Scholar
Boardman, F. K. (2014). The expressivist objection to prenatal testing: The experiences of families living with genetic disease. Social Science and Medicine, 107, 18–25. https://doi.org/10.1016/j.socscimed.2014.02.025
Boardman, F. K., & Hale, R. (2018). How do genetically disabled adults view selective reproduction? Impairment, identity, and genetic screening. Molecular Genetics and Genomic Medicine, 6(6), 941–956. https://doi.org/10.1002/mgg3.463
Article PubMed PubMed Central Google Scholar
Boardman, F. K., Clark, C., Jungkurth, E., & Young, P. J. (2020). Social and cultural influences on genetic screening programme acceptability: A mixed-methods study of the views of adults, carriers, and family members living with thalassemia in the UK. Journal of Genetic Counselling, 29(6), 1026–1040. https://doi.org/10.1002/jgc4.1231
Braun, V., & Clarke, V. (2022). Thematic analysis. Sage.
Bruni, T., Mameli, M., Pravettoni, G., & Boniolo, G. (2012). Cystic fibrosis carrier screening in Veneto (Italy): An ethical analysis. Medicine, Health Care and Philosophy, 15(3), 321–328. https://doi.org/10.1007/s11019-011-9347-7
Bryant, L. D., Ahmed, S., Ahmed, M., Jafri, H., & Raashid, Y. (2011). ‘All is done by Allah’. Understandings of Down syndrome and prenatal testing in Pakistan. Social Science and Medicine, 72(8), 1393–1399. https://doi.org/10.1016/j.socscimed.2011.02.036
Bunnik, E. M., Kater-Kuipers, A., Galjaard, R. J. H., & de Beaufort, I. (2020). Why NIPT should be publicly funded. Journal of Medical Ethics, 46(11), 783–784. https://doi.org/10.1136/medethics-2020-106218
Çaha, H. (2014). Selective abortion: The new face of eugenics. Turkish Journal of Business Ethics, 7(2), 70–90. https://doi.org/10.12711/tjbe.2014.7.2.0163
Carroll, J. C., Brown, J. B., Reid, A. J., & Pugh, P. (2000). Women’s experience of maternal serum screening. Canadian Family Physician, 46(3), 614–620.
PubMed PubMed Central Google Scholar
Council of Europe. (1997). Convention for the protection of human rights and dignity of the human being with regard to the application of biology and medicine: Convention on human rights and biomedicine. https://rm.coe.int/168007cf98
Cunningham, A. (2019). Cleaner, CRISPR constitution: Germline editing and fundamental rights. William and Mary Bill of Rights Journal, 27(3), 877–909.
de Montgolfier, S. (2018). Revisiting the nondirective principle of genetic counseling in prenatal screening. In S. Hostiuc (Ed.), Clinical ethics at the crossroads of genetic and reproductive technologies (pp. 99–111). Academic Press. https://doi.org/10.1016/B978-0-12-813764-2.00005-2
de Paor, A. (2016). Disability and genetics: New forms of discrimination? In P. Blanck & E. Flynn (Eds.), Routledge handbook of disability law and human rights (pp. 227–243). Routledge.
de Paor, A., & Blanck, P. (2016). Precision medicine and advancing genetic technologies—Disability and human rights perspectives. Laws, 5(3), 36. https://doi.org/10.3390/laws5030036
Delhove, J., Osenk, I., Prichard, I., & Donnelley, M. (2020). Public acceptability of gene therapy and gene editing for human use: A systematic review. Human Gene Therapy, 31, 20–46. https://doi.org/10.1089/hum.2019.197
Doble, B., Schofield, D., Evans, C. A., Groza, T., Mattick, J. S., Field, M., & Roscioli, T. (2020). Impacts of genomics on the health and social costs of intellectual disability. Journal of Medical Genetics, 57(7), 479–486. https://doi.org/10.1136/jmedgenet-2019-106445
Donnelly, J. (2013). Universal human rights in theory and practice. Cornell University Press.
Doxzen, K., & Halpern, J. (2020). Focusing on human rights: A framework for CRISPR germline genome editing ethics and regulation. Perspectives in Biology and Medicine, 63(1), 44–53. https://doi.org/10.1353/pbm.2020.0003
Engel, G. L. (1977). The need for a new medical model: A challenge for biomedicine. Science, 196(4286), 129–136. https://doi.org/10.1126/science.847460
Engel, G. L. (1981). The clinical application of the biopsychosocial model. The Journal of Medicine and Philosophy, 6(2), 101–124. https://doi.org/10.1093/jmp/6.2.101
Faragher, R. (2019). Research in the field of Down syndrome: Impact, continuing need, and possible risks from the New Eugenics. Journal of Policy and Practice in Intellectual Disabilities, 16(2), 130–133. https://doi.org/10.1111/jppi.12305
Farrell, P. M., White, T. B., Ren, C. L., Hempstead, S. E., Accurso, F., Derichs, N., Howenstine, M., McColley, S. A., Rock, M., Rosenfeld, M., Sermet-Gaudelus, I., Southern, K. W., Marshall, B. C., & Sosnay, P. R. (2017). Diagnosis of cystic fibrosis: Consensus guidelines from the cystic fibrosis foundation. The Journal of Pediatrics, 181, S4–S15. https://doi.org/10.1016/j.jpeds.2016.09.064
Guon, J., Wilfond, B. S., Farlow, B., Brazg, T., & Janvier, A. (2014). Our children are not a diagnosis: The experience of parents who continue their pregnancy after a prenatal diagnosis of trisomy 13 or 18. American Journal of Medical Genetics Part A, 164(2), 308–318. https://doi.org/10.1002/ajmg.a.36298
Haegele, J. A., & Hodge, S. (2016). Disability discourse: Overview and critiques of the medical and social models. Quest, 68(2), 193–206. https://doi.org/10.1080/00336297.2016.1143849
Hickerton, C. L., Aitken, M., Hodgson, J., & Delatycki, M. B. (2012). “Did you find that out in time?” New life trajectories of parents who choose to continue a pregnancy where a genetic disorder is diagnosed or likely. American Journal of Medical Genetics Part A, 158(2), 373–383. https://doi.org/10.1002/ajmg.a.34399
Hofmann, B. (2017). You are inferior! Revisiting the Expressivist Argument. Bioethics, 31(7), 505–514. https://doi.org/10.1111/bioe.12365
Karpin, I. A. (2016). Protecting the future well: Access to preconception genetic screening and testing and the right not to use it. Griffith Law Review, 25(1), 71–86. https://doi.org/10.1080/10383441.2016.1203274
Kazou, K. (2017). Analysing the definition of disability in the UN convention of the rights of persons with disabilities: Is it really based on a ‘social model’ approach? International Journal of Mental Health and Capacity Law, 25–48. https://doi.org/10.19164/ijmhcl.v2017i23
Kemper, J. M., Gyngell, C., & Savulescu, J. (2019). Subsidizing PGD: The moral case for funding genetic selection. Journal of Bioethical Inquiry, 16(3), 405–414. https://doi.org/10.1007/s11673-019-09932-2
Article PubMed PubMed Central Google Scholar
Kibel, M., & Vanstone, M. (2017). Reconciling ethical and economic conceptions of value in health policy using the capabilities approach: A qualitative investigation of non-invasive prenatal testing. Social Science and Medicine, 195, 97–104. https://doi.org/10.1016/j.socscimed.2017.11.024
Kumar, M. M. (2008). Implications of the 2007 American College of Obstetricians and Gynaecologists guidelines for prenatal testing: A sociological assessment (Publication No. 60400685) [Master’s thesis, Sarah Lawrence College]. Proquest Dissertations and Theses Global.
Lemke, T., & Rüppel, J. (2019). Social dimensions of preimplantation genetic diagnosis: A literature review. New Genetics and Society, 38(1), 80–112. https://doi.org/10.1080/14636778.2018.1549983
Li, H., Yang, Y., Hong, W., Huang, M., Wu, M., & Zhao, X. (2020). Applications of genome editing technology in the targeted therapy of human diseases: Mechanisms, advances and prospects. Signal Transduction and Targeted Therapy, 5(1), 1. https://doi.org/10.1038/s41392-019-0089-y
Article PubMed PubMed Central Google Scholar
Lord, J. E. (2013). Screened out of existence: The convention on the rights of persons with disabilities and selective screening policies. International Journal of Disability, Community & Rehabilitation, 12(2). http://www.ijdcr.ca/VOL12_02/articles/lord.shtml
Lord, J. E. (2014). Accommodating genes: Disability, discrimination and international human rights law. In G. Quinn, A. de Paor, & P. Blanck (Eds.), Genetic discrimination (pp. 226–242). Routledge. https://doi.org/10.4324/9780203674299
Lu, J., Webber, W. B., Romero, D., & Chirino, C. (2018). Changing attitudes toward people with disabilities using public media: An experimental study. Rehabilitation Counselling Bulletin, 61(3), 175–186. https://doi.org/10.1177/0034355217700820
MacKellar, C. (2021). Why human germline genome editing is incompatible with equality in an inclusive society. The New Bioethics, 27(1), 19–29.
Comments (0)